The role of membrane transporters in cellular resistance to anticancer nucleoside drugs

Cancer Treat Res. 2002:112:27-47. doi: 10.1007/978-1-4615-1173-1_2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biological Transport*
  • Capecitabine
  • Cell Membrane / metabolism*
  • Cladribine / therapeutic use
  • Cytarabine / therapeutic use
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Drug Resistance, Neoplasm*
  • Fluorouracil / analogs & derivatives
  • Gemcitabine
  • Humans
  • Tumor Cells, Cultured
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Cytarabine
  • Deoxycytidine
  • Cladribine
  • Capecitabine
  • Vidarabine
  • fludarabine
  • Fluorouracil
  • Gemcitabine